Ultragenyx Pharmaceutical Inc.
COMPOSITIONS AND METHODS FOR TREATMENT OF HEMOCHROMATOSIS
Last updated:
Abstract:
This application provides polynucleotides comprising a coding sequence for a functionally active hereditary hemochromatosis protein (HFE) or a functionally active fragment thereof. The invention further provides compositions comprising said polynucleotides and their use in methods of preventing or treating hemochromatosis in a subject.
Status:
Application
Type:
Utility
Filling date:
22 May 2020
Issue date:
14 Jul 2022